Add BrightSurf on Google Email

Irish surgeon identifies emerging area of medical science

Professor J. Calvin Coffey reclassified the mesentery as a single, continuous structure connecting the intestine to the abdomen, leading to potential advances in surgeries and disease diagnosis. Further study of mesenteric science could result in less invasive procedures, faster recovery times, and lower costs.

SourceUniversity of Limerick·JournalThe Lancet Gastroenterology & Hepatology·DateDec 19, 2016

The silver lining of an inflammatory bowel disease diagnosis

A study published by the American Gastroenterological Association found that adults with inflammatory bowel disease (IBD) diagnosed in childhood have better educational levels and higher annual incomes compared to their healthy counterparts. This news may alleviate anxiety for parents of newly diagnosed patients, providing reassurance ...

SourceAmerican Gastroenterological Association·JournalClinical Gastroenterology and Hepatology·DateOct 19, 2016

New breakthrough for IBS patients

A new study has found that faecal bacterial profiles can be used to predict which IBS patients are most likely to benefit from a low-FODMAP diet. The research identified differences in gut bacteria composition between those who responded and did not respond to the diet.

How the gut microbiome may help us prevent IBD

A recent study links a disease-associated microbial state to increased risk of developing IBD in genetically- and environmentally-susceptible individuals. Another study found that exposure to high altitude conditions triggers local acid sensing pathways leading to disease progression in IBD patients. Meanwhile, research highlights the ...

SourceAmerican Gastroenterological Association·JournalCellular and Molecular Gastroenterology and Hepatology·DateOct 14, 2016

UNC researchers help create key diagnostic measures for gastrointestinal disorders

A team of UNC School of Medicine researchers played a critical role in amending diagnostic criteria questionnaires for functional GI disorders. The Rome IV publication updates the diagnostic tools available to clinicians, incorporating research on symptoms and patient experiences. These changes improve treatment options for millions of...

SourceUniversity of North Carolina Health Care·JournalHYDROMETEOROLOGY AND ECOLOGY PROCEEDINGS OF THE RUSSIAN STATE HYDROMETEOROLOGICAL UNIVERSITY·DateJun 21, 2016

Stem cell transplant from young to old can heal stomach ulcers

Researchers discovered that stem cells isolated from young mice can accelerate repair of stomach ulcers when transplanted into older mice. Additionally, studies redefined the role of the gut microbiome in inflammatory bowel disease and found potential therapeutic applications for acute alcoholic liver disease using a scavenger compound.

SourceAmerican Gastroenterological Association·JournalCellular and Molecular Gastroenterology and Hepatology·DateJun 16, 2016

Tests show no specific gastrointestinal abnormalities in children with autism

A recent study published in the Journal of Pediatric Gastroenterology and Nutrition found that children with autism do not have a unique pattern of abnormal results on endoscopy or other tests for gastrointestinal disorders. The researchers analyzed the results of diagnostic tests in 61 children with autism being evaluated for GI sympt...

SourceWolters Kluwer Health·JournalJournal of Pediatric Gastroenterology and Nutrition·DateFeb 25, 2016

Feeding at-risk infants gluten increases risk of developing celiac disease

A study published in Clinical Gastroenterology and Hepatology found that feeding at-risk infants gluten until two years of age increases the risk of developing celiac disease. The research suggests that early gluten intake plays a role in disease course, particularly in children with genetic risk factors for celiac disease.

SourceAmerican Gastroenterological Association·JournalClinical Gastroenterology and Hepatology·DateNov 12, 2015

The role of intra-abdominal fat in IBD uncovered

A recent study published in Cellular and Molecular Gastroenterology and Hepatology found that intra-abdominal fat cells may promote inflammation in IBD patients. The research isolated and cultured pre-intra-abdominal fat cells from healthy subjects and those with IBD, revealing significant differences in signaling mediators produced by...

SourceAmerican Gastroenterological Association·JournalCellular and Molecular Gastroenterology and Hepatology·DateAug 5, 2015

Weight loss for a healthy liver

Two studies published in Gastroenterology found that weight loss through lifestyle modification or bariatric surgery significantly reduces NASH features. Lifestyle modifications resulted in a 10% weight reduction needed to reverse scarring, while bariatric surgery eliminated NASH in 85% of patients after one year.

SourceAmerican Gastroenterological Association·JournalGASTROENTEROLOGY·DateJul 27, 2015

'Biosimilars' for children with IBD need more research, ESPGHAN expert panel states

The European Society for Paediatric Gastroenterology and Nutrition recommends that children with inflammatory bowel disease should not be switched to biosimilar products without long-term studies. Post-marketing surveillance programs are also essential to confirm efficacy, safety, and immunogenicity of new biosimilars.

SourceWolters Kluwer Health·JournalJournal of Pediatric Gastroenterology and Nutrition·DateJul 13, 2015

Spouses & relatives of celiac disease patients at risk for autoimmune diseases

A nationwide observational cohort study found that spouses and first-degree relatives of celiac disease patients are at a higher risk of developing nonceliac autoimmune diseases. The most common conditions were systemic lupus erythematosus, type I diabetes mellitus, and sarcoidosis. Genetic, environmental, and ascertainment bias mechan...

SourceAmerican Gastroenterological Association·JournalClinical Gastroenterology and Hepatology·DateJun 30, 2015

Pinaverium shows promising results for treatment of irritable bowel syndrome

A clinical trial confirms that pinaverium is an effective and safe option for treating irritable bowel syndrome (IBS), with a significantly higher percentage of patients reporting improved symptoms compared to the placebo group. The medication was also associated with common side effects, but no severe adverse effects were reported.

SourceAmerican Gastroenterological Association·JournalClinical Gastroenterology and Hepatology·DateJun 30, 2015